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Introduction 
There are various expressions used to describe 
the procedure of therapeutic blood sampling, 
venipuncture, phlebotomy, venesection and 
bloodletting. A widely used expression across 
the English-speaking world is “phlebotomy”, 
derived from the Greek word “phleb”, which 
stands for “vein”, and “tómos” which means 
“incision”.  Phlebotomy is the process of opening 
a vein by incision in order to take blood for 
therapeutic treatment or diagnosis. One of the 
first people who recognized the importance of 
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veins and arteries was the Chinese Emperor 
known as the Yellow Emperor or Huang-Di (who 
ruled China in the 27th century BC). His famous 
remark was that “everything in the blood is under 
the control of the heart” (1). 
The ancient skill of bloodletting dates back to 
about three thousand years ago. Ancient Greeks, 
Egyptians, the peoples of Mesopotamia, the 
Maya and the Aztecs all knew the practice of 
blood-shedding, or bloodletting, as a treatment 
for diseases. This practice began with the 
Egyptians 1000 years before Christ and was 
Abstract 
Hemochromatosis is a hereditary disease caused by the mutation of genes responsible for regulating 
iron metabolism in the body. The mutation results in increased absorption of iron from food, which is 
then deposited in various organs and tissues. Due to the excessive decomposition of iron, organs, 
most commonly liver, heart and pancreas are damaged. The standard therapeutic procedure for the 
treatment of hereditary hemochromatosis is phlebotomy or venipuncture, which removes excess 
iron from the blood. The therapeutic procedure is carried out until the iron level returns to the 
reference interval. Ancient, three thousand years old bloodletting skills are still used to this day.  It 
was considered that the bloodletting establishes a good balance of bodily fluids referred to as 
eucrasia. Venipuncture was used to treat various diseases, with different amount of blood released, 
from half a liter to two liters, and sometimes even more. Venipuncture was applied not only for the 
treatment of existing diseases, but also as a preventive measure. To date, the use of therapeutic 
venipuncture has remained the gold standard for the treatment of hereditary hemochromatosis. 
The aim of this paper is to present a historical review of venipuncture or phlebotomy as a therapeutic 
procedure for the treatment of hemochromatosis.  
(Čuljak M. Hemochromatosis Treatment by Venipuncture Through History. SEEMEDJ 2018; 2(1); 44-
48) 
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popular among doctors until the late 19th 
century. Bloodletting was performed by shavers 
at the recommendation of a physician. 
Barbershops that performed the procedure 
were recognized by a barber’s pole with red and 
white stripes. Through history, bloodletting, 
especially with the help of leeches, was 
practiced as a treatment for existing diseases 
and as a method of prevention. Still, not 
everything was bad in the treatment by 
bloodletting. Medicinal leeches were used for 
improving circulation and blood flow during 
surgery. In some cultures, these treatments are 
still used today (2). 
According to Hippocrates (460 BC - 380 BC), a 
person’s personality (temperament) is 
determined by four body fluids (called 
“humors”): phlegm, yellow bile, black bile and 
blood. Hippocrates defined health as a good 
mixture (eucrasia), and disease as a bad mixture 
of these juices (dyscrasia). He used clinical 
observations to recognize the symptoms of 
certain diseases. All four classical elements: fire, 
earth, water and air were considered present in 
the blood, and it was believed that the letting of 
blood would restore the patient’s general 
wellbeing. Blood loss was considered beneficial 
because it was a way of balancing the fluids. 
Hippocrates believed that the fluids had to be 
perfectly balanced in order for the individual to 
have good health. Any imbalance was treated by 
bloodletting (3). 
In Greece, Galen of Pergamon (129-200 AD), a 
prominent Greek physician, surgeon and 
philosopher, first described that not only veins 
were filled with blood, but arteries as well, which 
were previously considered to be filled with air. 
He also believed in the humoral balance. He 
believed that blood should be released near the 
diseased part of the body. According to him, 
fever, termination of organ functions and 
headache are a result of excess blood, so the 
surgeon should tie the patient's hands to make 
the veins swell and become more pronounced 
in order to release a certain amount of blood (4). 
In Hebrew teaching, specifically in the Talmud, it 
is said that the release of blood should be 
carried out on certain days of the week and 
month. Christianity adopts similar guidelines. 
Islamic scholars also believe that the release of 
blood is very useful for the treatment of fevers. 
Physical signs that required bloodletting were 
redness, swelling, skin warm to the touch, and 
any sign of pus. The treatment consisted of 
making numerous cuts on the body,  and letting 
the blood flow into specially prepared 
receptacles. However, the treatment would be 
stopped, if the patient felt weak. Interestingly, 
there is no data on the number of deaths during 
these procedures (2,3). 
Hemochromatosis 
Primary hemochromatosis is a hereditary 
disease caused by HFE gene mutation on 
chromosome 6. This is the most common 
autosomal recessive hereditary disease of the 
Caucasian population in Northern European 
countries, with prevalence in Europe reported as 
1: 300. It is equally represented amongst both 
male and female populations. Sickness rarely 
occurs in the African and African American 
population, as well as in the Asian population. 
Men develop a clinical picture more often than 
women, about 10 times more often, the reason 
for this being the loss of iron in women during 
periods, birth and breastfeeding. Hereditary 
hemochromatosis is divided into four subtypes, 
and only type 1 is clinically important. A total of 
85-90% of patients with confirmed diagnosis of 
hemochromatosis are homozygotes for 
mutation C282Y (Y / Y genotype), while about 5% 
are heterozygotes for mutations C282Y, H63D 
and / or S65C. In individuals who did not 
demonstrate mutation C282Y, and who are 
heterozygotes for S65C and / or H63D, the 
possibility of developing a clinical picture of 
inherited hemochromatosis is extremely low 
(5.6). 
Diagnoses of hemochromatosis include 
laboratory diagnostics, radiological diagnostics 
and histological treatment. The clinical picture of 
hemochromatosis includes tiredness, 
hyperpigmentation (bronze skin color), loss of 
libido in men, diabetes, joint pain, cirrhosis of the 
liver and cardiomyopathy. 
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Laboratory diagnostics show elevated levels of 
serum iron and ferritin as well as increased 
transferrin saturation index. 
Applying venipuncture in the treatment 
of hemochromatosis 
Hemochromatosis was first described in Paris in 
1865 by Armand Trousseau, a French physician, 
who outlined the disease as a set of symptoms 
involving diabetes, skin pigmentation, and liver 
cirrhosis. Trousseau did not name the disease (2). 
Davis and Arrowsmith are attributed with the first 
report on the treatment of hemochromatosis 
which showed the value of venipuncture. In their 
report, they state that repeated venipunctures 
can remove harmful iron. To confirm the 
diagnosis of hemochromatosis, they carried out 
a liver biopsy. The first patient was a 69-year-old 
woman. Between March 1947 and February 
1949, 40 liters of blood were drawn from this 
patient. According to their report, all patients 
treated by bloodletting showed a general 
improvement (7). 
In 1954, Davey, Foxell and Kamp reported the 
case of a man at the age of 55 who was 
hospitalized in October 1950. The patient 
complained of abdominal pain that had lasted 
for 2 years, increased tiredness and gray and 
black pigmentation of the face, neck and upper 
arm. His liver was enlarged, spleen was not 
palpable, and free intra-abdominal fluid was 
found. He had not suffered from previous 
illnesses except for colon cancer surgery in 
1936. He drank plenty of beer daily. The tested 
urine showed glucose in the urine. Skin biopsy 
showed iron deposits, especially around the 
sweat glands. The patient was treated with 
repeated venesections. Over the course of two 
years, 31 liters of blood were drawn from the 
patient. Heavy anemia developed, although the 
patient showed subjective and objective 
improvement. The patient was last registered in 
1954 when his symptoms were pain in the joints. 
A report was published, claiming that 
venesection is an effective hemochromatosis 
treatment method (8). In 1965, a group of authors 
(Block, Moore, Wasi and Haiby) investigated a 
cohort of patients with hemochromatosis. In 
their research, a liver biopsy was performed 
prior to venesection, the findings of which 
suggested that liver lesions arise due to 
abnormal absorption of iron despite a normal 
diet (9). In an article published in 1969, Dr. R. 
Williamson reported that over a period of 5 
years, the mortality of patients treated with 
repeat venesection was 11%, while the mortality 
of untreated patients was more than 60% (10). 
Sargent et al. report on two hypotheses 
regarding hereditary hemochromatosis. One 
hypothesis is that inherited hemochromatosis 
results in excessive absorption of iron from food 
consumed by the patient, which is the deposited 
in the organs, where it causes toxic organ 
damage. The second hypothesis is that 
hereditary hemochromatosis is actually a form 
of cirrhosis that is further complicated by 
excessive iron from the patient’s diet. In eight 
patients with hereditary hemochromatosis, iron 
levels were tested before, during and after 
therapy (venipuncture). In all cases, serum iron 
levels after therapy were within normal limits, as 
were other blood indices. This is in favor of the 
hypothesis that inherited hemochromatosis is a 
disorder in the mechanism responsible for 
controlling iron absorption from food (11). 
Untreated hemochromatosis can result in death 
due to cardiac complications. Heart damage is 
manifested as cardiomyopathy, arrhythmia and 
heart failure. A period of 12 months is required to 
restore normal liver function and up to 30 
months to fully recover from angina. Continuous 
and controlled therapy (venipuncture) is needed 
to restore normal parameters (12). 
An early diagnosis of hereditary 
hemochromatosis has a tremendous 
significance in preventing the development of 
diabetes mellitus as well as hepatocellular 
carcinoma. Niederau et al. claim that patients 
who received timely therapy prior to the onset of 
cirrhosis did not develop hepatocellular 
carcinoma later. Early treatment with 
venipuncture prevents the formation of cirrhosis 
and attention should therefore be focused on 
early diagnosis of hereditary hemochromatosis 
(13). 
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A research conducted by a group of authors in 
Norway shows that the treating of hereditary 
hemochromatosis by venipuncture leads to a 
change in the level of some trace elements, 
including increased absorption of toxic elements 
such as copper. (14). 
Conclusion 
Therapeutic venipuncture or phlebotomy is the 
golden standard for the hemochromatosis 
therapy. In the procedure, 500 ml of blood 
containing 200 to 250 mg of iron is extracted. 
Standard procedures prescribe periodic 
venipuncture, approximately once a week, with 
the letting of 400-500 ml of blood, during the 
first 3 years, followed by 400-500 ml every 1-3 
months. Venipuncture is carried out until the 
levels of iron and ferritin drop to the lower limit 
of the normal reference interval. Venipuncture 
can be performed on younger patients 2-3 times 
a week. The aim is to achieve ferritin values 
below 50 ng / ml and a ferritin saturation index 
under 50% in serum. Most patients can tolerate 
quite well a week of undergoing the procedure, 
which should be performed until hematocrit falls 
below 37%. To monitor the therapeutic response, 
it is recommended to check serum saturation 
and serum ferritin levels every 2 to 3 months (15). 
Treatment of primary hemochromatosis by 
venipuncture is a safe and effective way of 
removing blood in order to reduce iron levels. 
Treatment is a lengthy process, usually lasting 
several years until iron values return to normal. 
Venipuncture improves the overall condition of 
the patient, alleviates the symptoms of fatigue, 
pain, and skin pigmentation. Regular therapy 
prevents liver complications, heart disease and 
diabetes (16). 
Despite the advances in technology, 
bloodletting as a therapeutic procedure has 
survived to this day as a controlled, supervised, 
safe and efficient treatment option. In this 
procedure, it is important to follow all the 
guidelines for proper blood drawing. The role of 
medical laboratory personnel in diagnosing and 
monitoring primary hemochromatosis is vital. 
Laboratory tests allow the physician to make a 
proper diagnosis and evaluate the overall 
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